Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer

Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality worldwide. Despite advances in treatment, the prognosis remains poor, highlighting the need for novel therapeutic strategies. The present review explores the potential of targeted epidermal growth factor receptor...

Full description

Bibliographic Details
Main Authors: Andreea Crintea, Anne-Marie Constantin, Alexandru C. Motofelea, Carmen-Bianca Crivii, Maria A. Velescu, Răzvan L. Coșeriu, Tamás Ilyés, Alexandra M. Crăciun, Ciprian N. Silaghi
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Journal of Functional Biomaterials
Subjects:
lung cancer
EGFR
non-small cell lung cancer
nanotherapy
Online Access:https://www.mdpi.com/2079-4983/14/9/466

Internet

https://www.mdpi.com/2079-4983/14/9/466

Similar Items